Friday 12^th April 2019

13:45      Welcome and introduction (D. Betticher, Fribourg)

SLL / CLL (M.G. Manz, Zürich)

13:50      Diagnostic procedures and criteria (M. Gregor, Luzern)

14:20      Molecular profiling (T. Zenz, Zürich)

14:50      Key questions in CLL research and treatment 2019 (B. Eichhorst, Köln)

15:20      Case presentations (N. Wegener, Zürich / T. Sutter, St. Gallen)

15:45      Coffee break

16:15      BTK/PI3K Inhibition, Bcl-2 Inhibitionand new targets (D. Rossi, Bellinzona)

16:45      Immunotherapy (checkpoint inhib mAb, BiTEs, CAR T cells) (A.M. Müller, Zürich)

17:15      Treatment of relapse (when and how) (T. Zenz, Zürich)

17:45      Chemo free treatment 1st line (Pro/Con, Roundtable) (Manz, Eichhorst, Gregor, Rossi, Zenz)        

18:30      Adjourn

Saturday 13^th April 2019

08:00      Multiple Myeloma Diagnostic Workup and Risk Stratification (R. Müller, Zürich)

08:30      Pathophysiology and druggable targets in MM (C. Driessen, St. Gallen)

09:00      Standard first-line Treatment for fit/HD-eligible (U. Mey, Chur)

09:30      Standard first-line Treatment for unfit/non-HD eligible (T. Zander, Luzern)

10:00      Case presentation (H. Kiesel, Zürich)

10:15      Coffee break

10:30      Treatment algorithms in Relapsed/Refractory Setting (C. Taverna, Münsterlingen)

11:00      New Therapies 2019 (from OMIBs and IMIDs to mABs, BITEs and CARTs) (H. Goldschmidt, Heidelberg)

11:30      AL-Amyloidosis (R. Schwotzer, Zürich)

12:00      Case presentation (R. Müller, Zürich)

12:15      End